Biogen (BIIB) Revenue — Quarter Ended Jun 30, 2024
Biogen's revenue increased in the quarter compared to the prior quarter. The top line also rose slightly versus the same period a year earlier.
Key takeaway
Quarter ended Jun 30, 2024 · FY2024 Q2
Biogen's revenue increased in the quarter compared to the prior quarter. The top line also rose slightly versus the same period a year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.5B
Revenue reported for this quarter.
Quarter-over-quarter
+7.6%
Change from the immediately preceding quarter.
Year-over-year
+0.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$9.7B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $2.5B | +0.9% |
| Dec 31, 2023 | $2.4B | -6.2% |
| Mar 31, 2024 | $2.3B | -7.0% |
| Jun 30, 2024 | $2.5B | +0.4% |
Revenue performance
Revenue grew from the preceding quarter, reversing a decline in the prior period. The year-over-year comparison showed a modest gain.
Quarterly comparison
Compared to the immediately preceding quarter, revenue improved. Against the same quarter one year earlier, revenue was higher.
What to watch
The company completed a major acquisition shortly after the quarter end, which may affect future results.